Meeting 13 th September 2017 Room 2 Seoul Convention Center - - PowerPoint PPT Presentation

meeting
SMART_READER_LITE
LIVE PREVIEW

Meeting 13 th September 2017 Room 2 Seoul Convention Center - - PowerPoint PPT Presentation

Pharmaceutical Forum of the Americas Meeting 13 th September 2017 Room 2 Seoul Convention Center Executive Committee President: Dr. Eduardo Savio (Uruguay) Vice-President: Dr. Laura Raccagni (Argentina) Treasurer: Q.F. Yolanda Zapata


slide-1
SLIDE 1

Pharmaceutical Forum of the Americas

Meeting

13th September 2017 Room 2 – Seoul Convention Center

slide-2
SLIDE 2

Executive Committee

President: Dr. Eduardo Savio (Uruguay) Vice-President: Dr. Laura Raccagni (Argentina) Treasurer: Q.F. Yolanda Zapata (Ecuador) Director of Education: Dr. Zully Vera (Paraguay) Director of Professional Development:Dr. Joselia Frade (Brazil)

Technical Secretariat:

Q.F. Carlos Lacava (Uruguay)

FIP Liasson Officer

  • Prof. Philip Schneider (USA)
slide-3
SLIDE 3

PAHO FIP PFA FEFAS FEPAFAR FFCC

slide-4
SLIDE 4

Costa Rica Paraguay Uruguay Argentina Brasil

slide-5
SLIDE 5

Observer Organizations

  • Consejo General de Colegios Oficiales de Farmacéuticos

de España

  • International Pharmaceutical Federation (FIP)
  • Federación Farmacéutica Sudamericana (FEFAS)
  • Federación Farmacéutica Panamericana (Fepafar)
  • Federación Farmacéutica Centroamericana y del Caribe
  • Pan American Health Organization (PAHO/WHO)
slide-6
SLIDE 6

Objective

To promote the dialogue and cooperation between the pharmaceuticals organizations of the region, FIP and PAHO/WHO, with the following aims:

slide-7
SLIDE 7

Aims

  • To contribute to the

health improvement through the CPD of pharmacists

  • Promotion of the

implementation of projects related to pharmacy practice in the member organizations

  • Adoption of PAHO/WHO

policies at pre and postgraduate levels, as well as continuos professional education.

  • Development of policy

declarations on health issues

slide-8
SLIDE 8

Training on Pharmaceutical Services based on Primary Healthcare: Virtual Course on Pharmaceutical Services based on Primary Healthcare for Managers Implementation period: 2015-2017

slide-9
SLIDE 9

Course of Pharmaceutical Services in Primary Health Care (PHC) for Managers 2014-2015 Target audience

Professionals involved in: § management, § administrative and technical activities in pharmaceutical services, § academic activities in public health careers and health sciences related to pharmacy, § at Ministries of Health, Social Security, universities or research centres working with the issue of pharmaceutical services.

slide-10
SLIDE 10

Background

  • Identifies functions

and areas where the participantes will build their projects:

  • Health education and promotion
  • Sanitary policies
  • Rational use of drugs
  • Pharmacovigilance
  • Dispensing
  • Pharmaceutical care
  • Selfcare

PAHO’s report 2010

slide-11
SLIDE 11

GPP Framework

A legal framework that: Defines who can practice pharmacy; Defines the scope of pharmacy practice; Ensures the integrity of the supply chain and the quality of medicines. A workforce framework that: Ensures the competence of pharmacy staff through CPD or CE programes, Defines the personnel resources needed to provide GPP. An economic framework that: Provides sufficient resources and incentives that are effectively used to ensure the activities undertaken in GPP.

slide-12
SLIDE 12

AIMS AND OBJECTIVES

  • General objective

To promote the development of pharmaceutical services based on primary healthcare, by building capacities on pharmaceutical services providers, leaders and managers.

  • Specific objectives

By the end of the course, participants should be able to:

  • Analyse and apply the acquired knowledge to improve pharmaceutical

services in their country or locality.

  • Identify and be able to develop the capacities required for implementing

pharmaceutical services.

  • Formulate a plan for shifting pharmaceutical services from a medicine-
  • riented to a people-oriented focus (Primary Healthcare).
slide-13
SLIDE 13

METHODOLOGY

  • This project started on January 2015 and finished on December 2016. PFA

initiated an active participation on this training proposal addressed to pharmacists in the Americas region with the fourth edition of the Virtual

  • Course. Previously PAHO had performed three editions.
  • During project development, the “Virtual Course of Pharmaceutical

Services based on Primary Healthcare to Managers” was offered on two modalities:

– With tutor (along three editions) – By self-study, under two options: without or with intervention project (one edition in each case).

In both cases, it was used the Virtual Campus for Public Health Platform from PAHO.

slide-14
SLIDE 14

METHODOLOGY

The three virtual courses with coaching were developed as is described below:

  • IV edition: 5 months, October 2014 to April 2015
  • V edition: 6 months, August 2015 to April 2016
  • VI edition: 6 months, June to November 2016

The self-study course without intervention project had three months duration September - December 2016 The self-study course with intervention project had an extra module which took place on 2017.

slide-15
SLIDE 15
  • Module 1: Social determinants of health and

primary healthcare

  • Module 2: Pharmaceutical services and their

components

  • Module 3: Pharmacists and change managament
  • Final interventional project

Programme

slide-16
SLIDE 16

ORGANIZATION

  • Academic coordination as well as a teaching and IT support.
  • In the three virtual courses with tutor, each group was integrated by 12 to

15 participants from the same country if possible.

  • Each group was guided by one tutor. Three to five participants worked

together to develop the final intervention project. They identified and developed a proposal with the aim of promoting or developing or strengthening the insertion of PS based on PHC in the health system at country level.

  • In the self-study course with intervention project participants came from

different countries, under the supervision of one tutor, sharing the same aim as above described.

  • Approval with 70% or higher in each module.
  • The final intervention project was presented by webEx as a closing activity
slide-17
SLIDE 17

Call and selection of partipants

  • Open call with limited places for all the editions with tutor. In some

national organizations the call was internally processed.

  • Selection process was carried out under the responsibility of the national
  • rganization in agreement with the national office of PAHO.
  • An open call with no limit of places was performed in the case of the self-

study course without intervention project. There was no selection done and all the registered participants were able to follow the activity.

  • There was a closed call carried out through national offices of PAHO in the

self-study course with final intervention project because a limited number

  • f places were available. As a pre requirement the participant should have

approved the self-study course.

slide-18
SLIDE 18

INDICATORS

Number of selected pharmacists, discriminated by country:

  • Argentina
  • Chile1
  • Colombia
  • Costa Rica
  • Ecuador
  • Paraguay
  • Uruguay
  • Venezuela2

135 37 30 27 14 27 115 41 17 17 9 21 10 107 25 17 30 03 15 16 01 Number of final intervention projects elaborated by country:

  • Argentina
  • Argentina-Venezuela
  • Chile
  • Colombia
  • Costa Rica
  • Ecuador
  • Paraguay
  • Uruguay

22 5 5 5 2 5 20 7 2 3 2 4 2 19 3 1 2 6 1 3 3 Electronic publication of final intervention projects Yes Yes Yes Number of final intervention projects presented in a Symposium organized by the PFA 8 final projects were selected; 7 were presented at the 18° Congress of South American Pharmaceutical Federation (FEFAS) held in Rio de Janeiro, October 2015. 7 final projects were selected and presented at the Argentinean Pharmaceutical Congress/76 FIP Congress, held in Buenos Aires (Argentina) August 2016. 8 final projects were selected to be presented at national or regional congresses: 4 at Peru (FEFAS, Lima, October 2017) 4 at Brazil (Conselho Federal de Farmácia, November 2017) Source: Data from final reports of the IV, V and VI Virtual Courses, elaborated by the academic coordination.

slide-19
SLIDE 19

GOALS

Goal 1

400 places were proposed to train pharmacists through this methodology, according to the following distribution:

  • 135 places for the fourth edition
  • 120 places for the fifth edition.
  • 145 places for the sixth edition
  • Achievement:

Virtual course with coaching Proposed Implemented Achieved IV edition 135 130 96% V edition 120 115 96% VI edition 145 96 66% Total 400 341 85%

slide-20
SLIDE 20

GOALS

Goal 2 One electronic publication including all the final integration projects already implemented in each edition (2015, 2016 and 2017)

slide-21
SLIDE 21
slide-22
SLIDE 22

Examples of Final projects 2016

  • Learning how to use your medicines (Argentine)
  • Development of strategies to improve adherence

in patient with respiratory diseases in a primary health center (Costa Rica)

  • Pharmacovigilance: research study. Why is there

underreported in Uruguay? (Uruguay)

slide-23
SLIDE 23

Grant given by the FIP Education and Research Foundation

Expenses Budget: US $12.000,00 $500,00 2 registration fees at RioPharma Congress/FEFAS Congress, Río de Janeiro (Brazil), October 2015 to participants who presented their final intervention projects at the Symposium organized by the Forum $6000,00 Support to national member organizations to pay 8 tutors, V edition. $3000,00 Support to academic coordinator, VI edition. $2500,00 IT support, VI edition. $12000,00 Total

slide-24
SLIDE 24

TOTAL BUDGET

  • National organizations (NMO): 80.000
  • PAHO: 20.000
  • FIP Foundation: 12.000
  • Forum (PFA): 5.000

Total budget: 117.000

NMO PAHO FIP PFA

slide-25
SLIDE 25

CONCLUSIONS

Outcome 1 The implementation of this project enabled the training of 577 pharmacists from the region of the Americas (including pharmacists from 7 countries which national pharmaceutical

  • rganizations are PFA’s members)
slide-26
SLIDE 26

CONCLUSIONS

Outcome 2 Seventy one final intervention/integration projects, in the most diverse health environments of the Americas, were fulfilled.

slide-27
SLIDE 27

Project 2017-2018 Approved by FIP Foundation

  • "Evaluation of the methodology and the impact of

the PFA/PAHO training in pharmaceutical services based on primary healthcare in the Americas region”

  • Aim: To assess the impact of the virtual course on

Pharmaceutical Services based on Primary Healthcare for managers that the PFA and PAHO have been organising since 2014, in developing specific competence by pharmacists in the region.

  • Responsible: Dr. Laura Raccagni (Argentina)
slide-28
SLIDE 28

Objectives

  • To determine how many pharmacists who have been trained with this

approach to Pharmaceutical Services have kept working within this concept, and how they have affected pharmacy practice in their countries.

  • To evaluate the impact of the course in raising awareness about the

importance of pharmaceutical services based on primary health care and creating ways to disseminate these concepts beyond the "boundaries" of the course (i.e., how the course has contributed to raising awareness about pharmaceutical services among the public, the profession and policy-makers).

  • To assess the methodology and the tools that have been used in the

course.

  • To evaluate how this approach has been considered in pre-graduate and

post-graduate education, at universitary level or at the professional

  • rganisation.
slide-29
SLIDE 29

Pharmaceutical Forum of the Americas

Leadership meeting

1st October 2015 Room 8 – Düsseldorf Convention Center

slide-30
SLIDE 30

Outcome: A new project or initiative

I dentifying the format of the project D efining its key components E stablishing its timeline A greeing upon its expected goals S etting the responsabilities of each patner

slide-31
SLIDE 31

Project approved by FIP 2016-2017

  • Infectious diseases transmitted by the

mosquito Aedes aegypti, dengue, chikungunya and zika: a challenge for health systems. Supporting pharmacists to contribute to improve public health in the Americas’ population

  • Responsible: Dr. Joselia Frade (Brazil)
slide-32
SLIDE 32